Conductive Hearing Loss Associates With Dementia, and Middle Ear Reconstruction Mitigates This Association: A Multinational Database Study

Author:

Urdang Zachary D.ORCID,Jain Amiti1,Li Marwin1,Haupt Thomas L.2,Wilcox Thomas O.3,Chiffer Rebecca C.3,Gurgel Richard K.4

Affiliation:

1. Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania

2. Howard University College of Medicine, Washington, DC

3. Department of Otolaryngology, Thomas Jefferson University

4. Department of Otolaryngology, University of Utah, Salt Lake City, Utah

Abstract

Objective To test the hypothesis that conductive hearing loss (CHL) is associated with dementia, and that middle ear reconstruction (MER) associates with improved outcomes for these measures in a multinational electronic health records database. Study Design Retrospective cohort study with propensity-score matching (PSM). Setting TriNetX is a research database representing about 110 million patients from the United States, Taiwan, Brazil, and India. Patients Subjects older than 50 years with no HL and any CHL (ICD-10: H90.0–2). Subjects of any age with and without any MER (CPT: 1010174). Main Outcome Measures Odds ratios (ORs) and hazard ratios with 95% confidence intervals (95% CIs) for incident dementia (ICD-10: F01, F03, G30). Results Of 103,609 patients older than 50 years experiencing any CHL, 2.74% developed dementia compared with 1.22% of 38,216,019 patients with no HL (OR, 95% CI: 2.29, 2.20–2.37). Of patients experiencing CHL, there were 39,850 who received MER. The average age was 31.3 years, with 51% female patients. A total of 343,876 control patients with CHL were identified; 39,900 patients remained in each cohort after 1:1 PSM for HL- and dementia-related risk factors. Matched risk for developing dementia among MER recipients was 0.33% compared with 0.58% in controls (OR: 0.58, 0.46–0.72). Conclusions CHL increases the odds for dementia, and MER improves the odds for incident dementia. This study represents the first population study on the topic of CHL, MER, and dementia.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3